Personalised risk communication for informed decision making about taking screening tests

AGK Edwards, G Naik, H Ahmed… - Cochrane database …, 2013 - cochranelibrary.com
Background There is a trend towards greater patient involvement in healthcare decisions.
Although screening is usually perceived as good for the health of the population, there are …

ACG clinical guidelines: colorectal cancer screening 2021

A Shaukat, CJ Kahi, CA Burke… - Official journal of the …, 2021 - journals.lww.com
Colorectal cancer (CRC) is the third most common cancer in men and women in the United
States. CRC screening efforts are directed toward removal of adenomas and sessile …

[HTML][HTML] Effectiveness of colorectal cancer (CRC) screening on all-cause and CRC-specific mortality reduction: a systematic review and meta-analysis

S Zheng, JJA Schrijvers, MJW Greuter, G Kats-Ugurlu… - Cancers, 2023 - mdpi.com
Simple Summary Colorectal cancer (CRC) screening is one of the most effective measures
to prevent CRC resulting in a decrease in CRC mortality. Mortality reduction (MR) from CRC …

Aspects of colorectal cancer screening, methods, age and gender

R Hultcrantz - Journal of internal medicine, 2021 - Wiley Online Library
Colorectal cancer (CRC) is, besides breast, prostate, lung and skin cancers, the most
common cancer worldwide and is suitable for screening. The incidence of CRC varies …

[HTML][HTML] Can polygenic risk scores contribute to cost-effective cancer screening? A systematic review

P Dixon, E Keeney, JC Taylor, S Wordsworth… - Genetics in …, 2022 - Elsevier
Purpose Polygenic risk influences susceptibility to cancer. We assessed whether polygenic
risk scores could be used in conjunction with other predictors of future disease status in cost …

The emerging field of polygenic risk scores and perspective for use in clinical care

T Yanes, AM McInerney-Leo, MH Law… - Human molecular …, 2020 - academic.oup.com
Genetic testing is used widely for diagnostic, carrier and predictive testing in monogenic
diseases. Until recently, there were no genetic testing options available for multifactorial …

[HTML][HTML] A scoping review of risk-stratified bowel screening: current evidence, future directions

JM Cairns, S Greenley, O Bamidele, D Weller - Cancer Causes & Control, 2022 - Springer
Purpose In this scoping review, we examined the international literature on risk-stratified
bowel screening to develop recommendations for future research, practice and policy …

The costs and benefits of risk stratification for colorectal cancer screening based on phenotypic and genetic risk: a health economic analysis

C Thomas, O Mandrik, CL Saunders… - Cancer Prevention …, 2021 - AACR
Population-based screening for colorectal cancer is an effective and cost-effective way of
reducing colorectal cancer incidence and mortality. Many genetic and phenotypic risk factors …

[HTML][HTML] Comparison of colonoscopy, fecal immunochemical test, and risk-adapted approach in a colorectal cancer screening trial (TARGET-C)

H Chen, J Shi, M Lu, Y Li, L Du, X Liao, D Wei… - Clinical …, 2023 - Elsevier
Background & Aims The screening yield and related cost of a risk-adapted screening
approach compared with established screening strategies in population-based colorectal …

[HTML][HTML] Economic evaluations of predictive genetic testing: A scoping review

Q Xi, S Jin, S Morris - PLoS One, 2023 - journals.plos.org
Predictive genetic testing can provide information about whether or not someone will
develop or is likely to develop a specific condition at a later stage in life. Economic …